Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04675515 · ClinicalTrials.gov registry record · NA
CORE: CO Monitoring for Reach and Efficacy in Tobacco Treatment for Cancer Patients
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT04675515 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 2 participants.
The verdict
NCT04675515, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the cessation success rates of an intensive tobacco treatment program in a patients undergoing cancer treatment at 30 days, 3 months and 6 months.
Interventions
- BEHAVIORAL Intensive Tobacco Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2021-01-19 |
| Est. Completion | 2024-02-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04675515
The ClinicalTrials.gov registry entry for NCT04675515 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intensive Tobacco Treatment is the first listed.
NCT04675515 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04675515 about?
NCT04675515 is a clinical study titled "CORE: CO Monitoring for Reach and Efficacy in Tobacco Treatment for Cancer Patients". The purpose of this study is to assess the cessation success rates of an intensive tobacco treatment program in a patients undergoing cancer treatment at 30 days, 3 months and 6 months.
What is the current status of trial NCT04675515?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2021-01-19. Estimated completion is 2024-02-16.
What interventions are being tested in trial NCT04675515?
The interventions under investigation include: Intensive Tobacco Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT04675515?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.